“Use of these products according to labeled instructions with an affected dosing cup is unlikely to result in serious side effects, and no reports related to overdose have been received to date,” according to a news release from Perrigo. “Consumers should be aware that an overdose of Guaifenesin DM may cause hyper excitability, rapid eye movements, changes in muscle reflexes, ataxia, dystonia, hallucinations, stupor and coma. Other effects have included nausea, vomiting, tachycardia, irregular heartbeat, seizures, respiratory depression and death.”
Perrigo has included the labels and batch numbers corresponding with potentially defective dosing cups in the release.
More articles on quality:
7 questions with a pediatrician in the thick of Flint’s lead poisoning crisis
TB outbreak leaves 3 dead in Alabama: 3 things to know
CDC: Patients test positive for hepatitis C in investigation at 2 Utah hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
